Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Senores Pharmaceuticals Ltd.

Senores Pharmaceutic

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹41.39 Cr.

EX-Date	Purpose
23 01 2025	Quarterly Results
15 05 2025	Audited Results
23 07 2025	Quarterly Results
06 11 2025	Quarterly Results
07 01 2026	Inter alia, to: 1. consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group including determination of issue price, in accordance with the Companies Act, 2013, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018, as amended, (the ?SEBI ICDR Regulations?) and all other applicable laws, as may be considered appropriate, subject to the approval of the Board of Directors, Shareholders and receipt of such regulatory / statutory approvals as may be required; and 2. transact ancillary and other business matters, as may be decided by the Board.
20 01 2026	Quarterly Results

News

16-DEC-2025

Senores Pharmaceuticals gets nod to acquire 100% share capital of Apnar Pharma

Upon consummation of the acquisition shall become a wholly owned subsidiary of the company

12:41 PM

05-DEC-2025

Senores Pharmaceuticals gets marketing authorizations for 10 products

The approvals provide Senores Pharmaceuticals with a strong platform to serve the Philippines

05:24 PM

13-AUG-2025

Senores Pharmaceuticals signs agreement to acquire ANDAs from Teva Pharmaceuticals USA, Inc

The acquisition will be funded through the Initial Public Offer proceeds raised by the company

10:47 AM

11-JUL-2025

Senores Pharmaceuticals to acquire 2.97% stake in Havix

The Management Committee of Board of Directors of the company, in their meeting held July 10, 2025, has approved the same

12:12 PM

21-MAY-2025

Senores Pharmaceuticals inks pact to acquire ANDA for Enalapril Maleate Tablets

Enalapril is indicated as a treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction

10:22 AM

09-MAY-2025

Senores Pharmaceuticals inks agreement to acquire ANDA for Tramadol Tablets

The acquisition will be funded through IPO proceeds raised by the company

09:22 AM

05-MAY-2025

Senores Pharmaceuticals inks agreement to acquire ANDA for Topiramate HCl 25, 50, 100, 200 mg tablets

Topiramate is indicated as a treatment of epilepsy and migraine

06:02 PM

12-MAR-2025

Senores Pharmaceuticals to acquire 3.73% paid up share capital of Havix

The shareholding of the Company in Havix will increase from 51.23% to 54.96%

12:23 PM

04-MAR-2025

Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy’s Laboratories

The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA

03:58 PM

27-FEB-2025

Senores Pharmaceuticals starts operations at greenfield API facility in Gujarat

This is Senores’ second API manufacturing facility, adding significantly to the existing API manufacturing capabilities

09:44 AM

21-FEB-2025

Senores Pharmaceuticals inks pact to acquire ANDA for Roflumilast 250 mcg, 500 mcg tablets

The acquisition will be funded through the IPO proceeds raised by SPL

10:38 AM

10-JAN-2025

Senores gets USFDA’s final nod for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet

Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions

09:22 AM

16-OCT-2024

Senores Pharmaceuticals gets Sebi’s nod to float IPO

The equity shares are proposed to be listed on the BSE and the NSE

12:22 PM